日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size

CD4+细胞计数≥800个/mm³时开始抗逆转录病毒治疗与较低的人类免疫缺陷病毒(HIV)病毒库大小相关。

Rasmussen, Thomas A; Ahuja, Sunil K; Kuwanda, Locadiah; Vjecha, Michael J; Hudson, Fleur; Lal, Luxshimi; Rhodes, Ajantha; Chang, Judy; Palmer, Sarah; Auberson-Munderi, Paula; Mugerwa, Henry; Wood, Robin; Badal-Faesen, Sharlaa; Pillay, Sandy; Mngqibisa, Rosie; LaRosa, Alberto; Hildago, Jose; Petoumenos, Kathy; Chiu, Chris; Lutaakome, Joseph; Kitonsa, Jonathan; Kabaswaga, Esther; Pala, Pietro; Ganoza, Carmela; Fisher, Katie; Chang, Christina; Lewin, Sharon R; Wright, Edwina J

No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts

CD4+ T细胞计数大于500的成年人立即接受抗逆转录病毒治疗并无神经认知方面的优势。

Wright, Edwina J; Grund, Birgit; Robertson, Kevin R; Cysique, Lucette; Brew, Bruce J; Collins, Gary L; Poehlman-Roediger, Mollie; Vjecha, Michael J; Penalva de Oliveira, Augusto César; Standridge, Barbara; Carey, Cate; Avihingsanon, Anchalee; Florence, Eric; Lundgren, Jens D; Arenas-Pinto, Alejandro; Mueller, Nicolas J; Winston, Alan; Nsubuga, Moses S; Lal, Luxshimi; Price, Richard W

Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial

立即启动抗逆转录病毒疗法对CD4细胞计数超过500个/μL的HIV感染者发生严重细菌感染风险的影响:一项随机对照试验的次要结局结果

O'Connor, Jemma; Vjecha, Michael J; Phillips, Andrew N; Angus, Brian; Cooper, David; Grinsztejn, Beatriz; Lopardo, Gustavo; Das, Satyajit; Wood, Robin; Wilkin, Aimee; Klinker, Hartwig; Kantipong, Pacharee; Klingman, Karin L; Jilich, David; Herieka, Elbushra; Denning, Eileen; Abubakar, Ibrahim; Gordin, Fred; Lundgren, Jens D

Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals

循环 miR-122 和 miR-200a 作为接受抗逆转录病毒疗法治疗的 HIV-1 感染者致命性肝病的生物标志物

Murray, Daniel D; Suzuki, Kazuo; Law, Matthew; Trebicka, Jonel; Neuhaus Nordwall, Jacquie; Johnson, Margaret; Vjecha, Michael J; Kelleher, Anthony D; Emery, Sean

Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection.

在 HIV 感染期间,白细胞介素 6 比高敏 C 反应蛋白或 D-二聚体更能预测临床事件

Borges Álvaro H, O'Connor Jemma L, Phillips Andrew N, Neaton James D, Grund Birgit, Neuhaus Jacqueline, Vjecha Michael J, Calmy Alexandra, Koelsch Kersten K, Lundgren Jens D

Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials

经验教训:大型公共资助国际试验的基础设施建设和财务管理

Larson, Gregg S; Carey, Cate; Grarup, Jesper; Hudson, Fleur; Sachi, Karen; Vjecha, Michael J; Gordin, Fred

Factors Associated With Plasma IL-6 Levels During HIV Infection.

HIV感染期间血浆IL-6水平的相关因素

Borges Álvaro H, O'Connor Jemma L, Phillips Andrew N, Rönsholt Frederikke F, Pett Sarah, Vjecha Michael J, French Martyn A, Lundgren Jens D

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study

血清中循环的microRNA与免疫激活的可溶性生物标志物相关,但不能预测接受抗逆转录病毒疗法治疗的HIV-1感染者的死亡率:一项病例对照研究

Murray, Daniel D; Suzuki, Kazuo; Law, Matthew; Trebicka, Jonel; Neuhaus, Jacquie; Wentworth, Deborah; Johnson, Margaret; Vjecha, Michael J; Kelleher, Anthony D; Emery, Sean

Determinants of IL-6 levels during HIV infection

HIV感染期间IL-6水平的决定因素

Borges, Alvaro H; O'Connor, Jemma L; Phillips, Andrew N; Rönsholt, Frederikke F; Pett, Sarah; Vjecha, Michael J; French, Martyn A; Lundgren, Jens D

Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect

SMART研究两组受试者的神经认知测试表现均有所提高:练习效应的影响

Grund, Birgit; Wright, Edwina J; Brew, Bruce J; Price, Richard W; Roediger, Mollie P; Bain, Margaret P; Hoy, Jennifer F; Shlay, Judith C; Vjecha, Michael J; Robertson, Kevin R